It is a business services private limited company based in Mumbai, Maharashtra, India, established in 2006.
2006 | Mumbai, Maharashtra, India | ActiveWyeth Pharmaceuticals India Private Limited, a active private limited company, was established on 03 February 2006 in Mumbai, Maharashtra, India. Engaging in business support services within the support service to organizations sector, it holds CIN: U24230MH2006PTC159507. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹7.00 Cr and a paid-up capital of ₹6.70 Cr.
Formerly known as Wyeth Pharmaceuticals India Limited. It upholds a compliant status. Its leadership includes Darshak Pradip Bhagat (Director), Prajeet Nair (Director). Past directors included Doraiswamy Sankaran Pallassana, Mohanish Lalitchandra Anand, Shilpa Prashant Patil. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at The Capital, 1802 / 1901, Plot No. C-70, G-Block Bandra Kurla Complex, Bandra (East), Mumbai, Maharashtra, 400051.
U24230MH2006PTC159507
159507
03 February 2006
₹7.00 Cr
₹6.70 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Wyeth Pharmaceuticals India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Darshak Pradip Bhagat | Director | 30 Mar 2020 | Current |
| Prajeet Nair | Director | 07 May 2015 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Whole-Time Director | 13 Sep 2012 | Past |
| Pramod Abcsdd | Additional Director | 06 Sep 2010 | Past |
| Pramod Abcsdd | Director | 29 Dec 2010 | Past |
| Pramod Abcsdd | Nominee Director | 26 Jul 2007 | Past |
| Pramod Abcsdd | Director | 19 Nov 2012 | Past |
| Pramod Abcsdd | Director | 12 Aug 2013 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Wyeth Pharmaceuticals India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 117.18% increase. The company also saw a slight decrease in profitability, with a 7.11% decrease in profit. The company's net worth moved up by a moderate rise of 1.38%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Wyeth Pharmaceuticals India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Wyeth Pharmaceuticals India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Wyeth Pharmaceuticals India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Wyeth Pharmaceuticals India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Wyeth Pharmaceuticals India Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Wyeth Pharmaceuticals India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.
Progress on Darshak Pradip Bhagat was appointed as a Director was appointed as a Director on 30 Mar 2020 & has been associated with this company since 5 years 8 months . was documented.
Progress on Prajeet Nair was appointed as a Director was appointed as a Director on 07 May 2015 & has been associated with this company since 10 years 6 months . was documented.
The activity Wyeth Pharmaceuticals India Private Limited was registered on 03 Feb 2006 with Roc Mumbai & aged 19 years 9 months as per MCA records. was completed.
The CIN of Wyeth Pharmaceuticals India Private Limited is U24230MH2006PTC159507.
Wyeth Pharmaceuticals India Private Limited is headquartered at The Capital, 1802 / 1901, Plot No. C-70, G-Block Bandra Kurla Complex, Bandra (East), Mumbai, Maharashtra, 400051.
Wyeth Pharmaceuticals India Private Limited was incorporated on 03 February 2006.
The current directors of Wyeth Pharmaceuticals India Private Limited are
The primary industry of Wyeth Pharmaceuticals India Private Limited is Support Service To Organizations.
Wyeth Pharmaceuticals India Private Limited is unlisted.
The authorized capital of Wyeth Pharmaceuticals India Private Limited is ₹7.00 Cr, and the paid-up capital is ₹6.70 Cr.
The compliance status of Wyeth Pharmaceuticals India Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX